
TRIMTECH Therapeutics Raises $31M Seed Funding for Neurodegenerative Disease Treatment
TRIMTECH Therapeutics Secures $31M in Seed Funding to Advance Targeted Protein Degradation Treatments for Neurodegenerative Diseases TRIMTECH Therapeutics, a biotech company focused on developing therapies using targeted protein degradation (TPD) for neurodegenerative diseases, has announced the successful completion of its…












